Drugplain

dabigatran etexilate 150 mg/1

dabigatran etexilate · CAPSULE · Apotex Corp.

No Recall History
Plain English

dabigatran etexilate is a capsule containing dabigatran etexilate at 150 mg/1, taken oral. Manufactured by Apotex Corp..

Key Facts

Brand Name
dabigatran etexilate
Generic Name
dabigatran etexilate
NDC Code (Product)
60505-4348
Manufacturer
Apotex Corp.
Strength
150 mg/1
Dosage Form
CAPSULE
Route
ORAL
Marketing Status
Application #
ANDA208070
Marketing Start
02/13/2024

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

drug interaction142 reports
gastrointestinal haemorrhage96 reports
hypotension71 reports
anaemia55 reports
atrial fibrillation55 reports
fall53 reports
dizziness51 reports
dyspnoea50 reports
haemorrhage50 reports
drug ineffective46 reports

Frequently Asked Questions

What is dabigatran etexilate used for?

dabigatran etexilate contains dabigatran etexilate. It is a capsule taken oral. Consult your doctor for specific uses.

Is dabigatran etexilate a controlled substance?

dabigatran etexilate is not classified as a controlled substance by the DEA.

What is the generic name for dabigatran etexilate?

The generic name for dabigatran etexilate is dabigatran etexilate. There are 11 other brand versions of dabigatran etexilate.

What is the NDC code for dabigatran etexilate 150 mg/1?

The NDC (National Drug Code) for dabigatran etexilate 150 mg/1 is 60505-4348, listed by Apotex Corp..